期刊文献+

动态监测甘精胰岛素与预混胰岛素治疗期间老年2型糖尿病患者血糖漂移和低血糖发生率 被引量:37

DGMS-revealed glycemic excursions and hypoglycemic incidence in type 2 diabetes mellitus in the elderly during insulin glargine versus mixed insulin treatment
原文传递
导出
摘要 用动态血糖监测的方法比较甘精胰岛素联合口服瑞格列奈,与每日注射2次预混胰岛素(诺和灵30R)治疗的老年2型糖尿病患者血糖漂移水平和低血糖发生情况。发现甘精组血糖漂移度明显低于预混组;低血糖事件也明显少于预混组。因此,老年2型糖尿病患者每天1次甘精胰岛素加瑞格列奈口服,在血糖达到良好控制时,血糖的漂移程度更低,低血糖发生率低。 To compare the degree of glycemic excursions by dynamic glucose monitoring in type 2 diabetes in the elderly when their HbA1c≤6.5. The mean blood glucose level and hypoglycemia incidence were observed. The amplitude of glycemic excursions revealed by DGMS was significantly lower in insulin glargine group than in mixed insulin group ( P 〈 0.05 ). The incidence of hypoglycemia were lower in glargine group than in mixed insulin group( P〈0. 05 ).
作者 王平 祝开思
机构地区 解放军
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2010年第2期127-128,共2页 Chinese Journal of Diabetes
关键词 甘精胰岛素 预混胰岛素 瑞格列奈 糖尿病 2型 动态血糖监测 Insulin glargine Mixed insulin Repaglinide Dynamic glucose monitoring
  • 相关文献

参考文献5

  • 1Maia FF, Araujo LR. Metabolic/glycemie control accuracy, effect and complications of the continuous glucose monitoring system in diabetic patients. Rev Assoc Med Bras, 2006,52 : 395-400.
  • 2喻明,周健,项坤三,陆惠娟,马晓静,陆蔚.动态监测糖耐量正常者血糖水平的漂移变化[J].中华医学杂志,2004,84(21):1788-1790. 被引量:50
  • 3Maia FF, Araujo LR. Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients. Diabetes Res Clin Pract, 2007,75 : 30-34.
  • 4周健,喻明,贾伟平,李青,李鸣,马晓静,陆蔚,项坤三.应用动态血糖监测系统评估2型糖尿病患者日内及日间血糖波动幅度[J].中华内分泌代谢杂志,2006,22(3):286-288. 被引量:178
  • 5Muggeo M, Verlato G, Bonora E, et al. Long-term instability ot fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation, 1997,96 : 1750-1754.

二级参考文献17

  • 1喻明,周健,项坤三,陆惠娟,马晓静,陆蔚.动态监测糖耐量正常者血糖水平的漂移变化[J].中华医学杂志,2004,84(21):1788-1790. 被引量:50
  • 2American Diabetes Association. Clinical practice recommendations. Diabetes Care,2001, 24(Suppl.1): 5-24.
  • 3World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.
  • 4Mastrototaro J. The MiniMed continuous glucose monitoring system(CGMS). J Pediatr Endocriol Metab, 1999,12:751-758.
  • 5Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther,2000,2:49-56.
  • 6Cheyne EH, Cavan DA, Kerr D. Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. Diabetes Technol Ther,2002,4:607-613.
  • 7Boyne MS, Silver DM, Kaplan J, et al. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes, 2003, 52:2790-2794.
  • 8Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous glucose monitoring system. Diabetes Care, 2001,24:2030-2034.
  • 9Boland E, Monsod T, Delucia M, et al. Limitations of conventional methods of self-monitoring of blood glucose. Diabetes Care,2001,24: 1858-1862.
  • 10Rohlfing CL, Wiedmeyer HM, Litter RR, et al. Defining the relationship between plasma glucose and HbA1c. Diabetes Care, 2002,25:275-278.

共引文献218

同被引文献224

引证文献37

二级引证文献246

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部